Bibliographic Details
| Title: |
Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial |
| Authors: |
Brose, Marcia S a, *, Robinson, Bruce b, Sherman, Steven I c, Krajewska, Jolanta d, Lin, Chia-Chi e, Vaisman, Fernanda f, Hoff, Ana O g, Hitre, Erika h, Bowles, Daniel W i, Hernando, Jorge j, Faoro, Leonardo k, Banerjee, Kamalika k, Oliver, Jennifer W k, Keam, Bhumsuk l, Capdevila, Jaume j |
| Source: |
In The Lancet Oncology August 2021 22(8):1126-1138 |
| Database: |
ScienceDirect |
